|
92
|
305
|
3r7oA |
Structure of dually phosphorylated c-met receptor kinase in complex with an mk-2461 analog |
|
90
|
324
|
5x26A |
Crystal structure of egfr 696-1022 l858r in complex with sklb(3) |
|
86
|
325
|
5x2kA |
Crystal structure of egfr 696-1022 t790m in complex with wz4003 |
|
84
|
324
|
5x28A |
Crystal structure of egfr 696-1022 l858r in complex with sklb(6) |
|
87
|
324
|
5x27A |
Crystal structure of egfr 696-1022 l858r in complex with sklb(5) |
|
92
|
324
|
5x02A |
Crystal structure of the flt3 kinase domain bound to the inhibitor ff-10101 |
|
89
|
315
|
5x2fA |
Crystal structure of egfr 696-1022 t790m/v948r in complex with sklb(6) |
|
87
|
315
|
5wnoA |
Crystal structure of c. elegans let-23 kinase domain complexed with amp-pnp |
|
84
|
304
|
5wr7A |
Crystal structure of trk-a complexed with a selective inhibitor ch7057288 |
|
39
|
214
|
5w59B |
Crystal structure of a monomeric human fgf9 in complex with the ectodomain of human fgfr1c |
|
25
|
213
|
5w21C |
Crystal structure of a 1:1:1 fgf23-fgfr1c-aklotho ternary complex |
|
136
|
502
|
5wb8A |
Crystal structure of the epidermal growth factor receptor extracellular region in complex with epigen |
|
137
|
500
|
5wb7A |
Crystal structure of the epidermal growth factor receptor extracellular region in complex with epiregulin |
|
19
|
102
|
5vxzC |
High-affinity axl decoy receptor |
|
1
|
10
|
5vz5C |
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the human major histocompatibility complex class i molecule hla-b*1501 |
|
85
|
303
|
5vndA |
Crystal structure of fgfr1-y563c (fgfr4 surrogate) covalently bound to h3b-6527 |
|
82
|
283
|
5uwdA |
Crystal structure of egfr kinase domain (l858r, t790m, v948r) in complex with the covalent inhibitor co-1686 |
|
84
|
302
|
5uq0A |
Fgfr1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide |
|
89
|
302
|
5ur1A |
Fgfr1 kinase domain complex with sn37333 in reversible binding mode |
|
87
|
293
|
5u6cA |
Crystal structure of the mer kinase domain in complex with a macrocyclic inhibitor |
|
99
|
306
|
5ui0A |
Crystal structure of the tyrosine kinase domain of fgf receptor 2 harboring an e565a/k659m double gain-of-function mutation |
|
93
|
297
|
5uglA |
Crystal structure of fgf receptor 2 tyrosine kinase domain harboring the d650v activating mutation |
|
88
|
297
|
5ugxA |
Crystal structure of the tyrosine kinase domain of fgf receptor 2 harboring a e565a/d650v double gain-of-function mutation |
|
86
|
283
|
5ugaA |
Crystal structure of the egfr kinase domain (l858r, t790m, v948r) in complex with 4-(4-{[2-{[(3s)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9h-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium |
|
91
|
324
|
5ugbA |
Crystal structure of the egfr kinase domain in complex with 4-(4-{[2-{[(3s)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9h-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium |
|
91
|
332
|
5uafA |
Met tyrosine kinase inhibition enhances the antitumor efficacy of an hgf antibody |
|
87
|
284
|
5ug9A |
Crystal structure of the egfr kinase domain (l858r, t790m, v948r) in complex with a covalent inhibitor n-[(3r,4r)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1h-pyrazol-4-yl)amino]-9-(propan-2-yl)-9h-purin-2-yl}pyrrolidin-3-yl]propanamide |
|
146
|
880
|
5u8qA |
Structure of the ectodomain of the human type 1 insulin-like growth factor receptor in complex with igf-i |
|
80
|
296
|
5uhnA |
Crystal structure of the tyrosine kinase domain of fgf receptor 2 harboring a n549h/e565a double gain-of-function mutation |
|
87
|
284
|
5ugcA |
Crystal structure of the egfr kinase domain (l858r, t790m, v948r) in complex with a covalent inhibitor n-[(3r,4r)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1h-pyrazol-4-yl)amino]-9-methyl-9h-purin-2-yl}pyrrolidin-3-yl]propanamide |
|
90
|
289
|
5u8lA |
Crystal structure of egfr kinase domain in complex with a sulfonyl fluoride probe xo44 |
|
89
|
332
|
5uabA |
Met tyrosine kinase inhibition enhances the antitumor efficacy of an hgf antibody |
|
88
|
284
|
5ug8A |
Crystal structure of the egfr kinase domain (l858r, t790m, v948r) in complex with a covalent inhibitor n-[(3r,4r)-4-fluoro-1-{6-[(1-methyl-1h-pyrazol-4-yl)amino]-9-(propan-2-yl)-9h-purin-2-yl}pyrrolidin-3-yl]propanamide |
|
82
|
293
|
5u6bA |
Structure of the axl kinase domain in complex with a macrocyclic inhibitor |
|
0
|
8
|
5u1mB |
Structure of the irs-1 ptb domain bound to the juxtamembrane region of the insulin receptor |
|
70
|
285
|
5td2A |
Structure-based optimization of 1h-imidazole-2-carboxamides as axl kinase inhibitors utilizing a mer mutant surrogate |
|
85
|
623
|
5t89X |
Crystal structure of vegf-a in complex with vegfr-1 domains d1-6 |
|
87
|
302
|
5t3qA |
Crystal structure of the c-met kinase domain in complex with a pyrazolone inhibitor |
|
57
|
194
|
5sx5M |
Crystal structure of panitumumab in complex with epidermal growth factor receptor domain 3 mutant s468r. |
|
52
|
191
|
5sx4M |
Crystal structure of panitumumab in complex with epidermal growth factor receptor domain 3. |
|
43
|
231
|
5oyjC |
Crystal structure of vegfr-2 domains 4-5 in complex with darpin d4b |
|
79
|
370
|
5o4oC |
Her3 in complex with fab mf3178 |
|
12
|
44
|
5ob4A |
Nmr spatial structure of her2 tm domain dimer in dpc micelles. |
|
136
|
542
|
5o4gC |
Her2 in complex with fab mf3958 |
|
117
|
604
|
5o7pC |
Her3 in complex with fab mf3178 |
|
75
|
299
|
5nwzA |
Fibroblast growth factor receptor 4 kinase domain (449-753) in complex with irreversible ligand cga159527 |
|
91
|
301
|
5o49A |
Human fgf in complex with a covalent inhibitor |
|
86
|
301
|
5o4aA |
Human fgf in complex with a covalent inhibitor |
|
86
|
301
|
5nudA |
Fibroblast growth factor receptor 4 kinase domain (449-753) in complex with irreversible ligand cga159527 |
|
3
|
25
|
5nz9A |
Nmr structure of an epha2-sam fragment |
